GlassScriptPhysician profile
Irina Lelchuk
NPI 1942202437
$1,642.80
in general payments reported to CMS, 2019-2025
15 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $42.22 · 2021: $243 · 2022: $223 · 2023: $109 · 2024: $590 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $783.14 | 2020-2025 | Breztri, Airsupra |
| Azurity Pharmaceuticals, INC. | $168.09 | 2023-2025 | Horizant, Edarbi, Edarbi |
| Arbor Pharmaceuticals, INC. | $131.33 | 2021 | |
| Medtronic, INC. | $127.23 | 2022 | |
| Smith+Nephew, INC. | $111.81 | 2019-2023 | Collagenase Santyl |
| Janssen Biotech, INC. | $84.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $68.22 | 2021 | |
| Abbvie INC. | $30.80 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.07 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.99 | 2022 | |
| Epi Health, LLC | $21.20 | 2022 | |
| Acella Pharmaceuticals, LLC | $20.00 | 2023 | NP Thyroid 60 |
| Pfizer INC. | $17.90 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $15.00 | 2019 | |
| Lilly USA, LLC | $12.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Lelchuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.